← Back to Search

Education Counseling Session for PSA Screening for Prostate Cancer

N/A
Waitlist Available
Led By Danil Makarov, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 3
Awards & highlights

Study Summary

This trial will test whether a Community Health Worker-led decision coaching program can help Black men make better decisions about prostate cancer screening, communication with their doctor, and utilization of the PSA test.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 3
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 3 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Decision Quality Score
Change in Measure of Informed Choice Attitudes Score
Change in Patient Knowledge Survey Score from Post-Coaching Session to Post-Appointments
+1 more
Secondary outcome measures
Change in Decision Self-Efficacy Scale Score
Change in Decisional Conflict Scale Score
Change in Perceived Efficacy in Patient-Physician Interactions Questionnaire (PEPPI) Score
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
A decision aid along with decision coaching on PSA screening from a Community Health Worker (CHW). The intervention will be administered directly prior to the participant's appointment with their provider.
Group II: Control GroupActive Control1 Intervention
A decision aid along with CHW interaction on dietary and lifestyle modification to serve as an attention control. The intervention will be administered directly prior to the participant's appointment with their provider.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Education Counseling Session for PSA Screening
2019
N/A
~170

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,368 Previous Clinical Trials
839,564 Total Patients Enrolled
24 Trials studying Prostate Cancer
5,077 Patients Enrolled for Prostate Cancer
National Institute on Minority Health and Health Disparities (NIMHD)NIH
382 Previous Clinical Trials
1,215,999 Total Patients Enrolled
4 Trials studying Prostate Cancer
1,968 Patients Enrolled for Prostate Cancer
Danil Makarov, MDPrincipal InvestigatorNYU Langone Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How can I participate in this clinical trial?

"140 participants between the ages of 40 and 69 are required for this prostate cancer trial. Eligibility is determined by age, with candidates needing to be within these parameters in order to participate."

Answered by AI

Does this experimental program admit participants aged 85 and over?

"This study is limited to those aged 40-69 years old. There are 76 studies open for participants under 18, and 1,315 available for people over 65."

Answered by AI

Is this medical trial actively seeking participants?

"The clinical trial posted on October 15th 2019 is not presently looking for participants, although there are 1,321 other medical studies actively accepting enrollees at this time. The information was last updated August 4th 2022 according to the registry hosted on clinicialtrials.gov."

Answered by AI
~29 spots leftby Apr 2025